Skip to main content
. 2020 Apr 30;14:781–793. doi: 10.2147/PPA.S239196

Table 3.

Patient Characteristics

Characteristic Total Participants (N=224)*
Children (3–11 Years) (n=70) Adolescents (12–18 Years) (n=79) Adults (≥25 Years) (n=75)
Age (years)
 Mean (SD) 8.7 (2.2) 13.9 (1.4) 50.3 (11.7)
 Min-Max 3.0-11.0 12.0-17.0 28.0-87.0
Gender (n, %)
 Male 44 (62.9%) 60 (75.9%) 25 (33.3%)
 Female 26 (37.1%) 19 (24.1%) 50 (66.7%)
Location of residency (n, %)
 Arizona 2 (2.9%) 5 (6.3%) 1 (1.3%)
 Arkansas -- -- 1 (1.3%)
 California 8 (11.4%) 9 (11.4%) --
 District of
 Columbia
-- -- 1 (1.3%)
 Florida 12 (17.1%) -- 2 (2.7%)
 Georgia 1 (1.4%) -- --
 Kansas -- -- 2 (2.7%)
 Louisiana -- -- 3 (4.0%)
 Nevada 28 (40.0%) 38 (48.1%) --
 North Carolina -- 1 (1.3%) --
 Ohio 18 (25.7%) 25 (31.6%) 14 (18.7%)
 Pennsylvania 1 (1.4%) -- 13 (17.3%
 Texas -- -- 38 (50.7%)
 West Virginia -- 1 (1.3%) --
Race (n, %)
 Asian 5 (7.1%) 4 (5.1%) 0 (0.0%)
 Black or
 African-American
2 (2.9%) 2 (2.5%) 1 (1.3%)
 Native Hawaiian or Other Pacific Islander 0 (0.0%) 1 (1.3%) 0 (0.0%)
 White 55 (78.6%) 63 (79.7%) 71 (94.7%)
 Other 8 (11.4%) 9 (11.4%) 3 (4.0%)
Ethnicity (n, %)
 Hispanic or
 Latino
6 (8.6%) 14 (17.7%) 5 (6.7%)
 Not Hispanic
 or Latino
64 (91.4%) 65 (82.3%) 70 (93.3%)
 Not answered 0 (0.0%) 0 (0.0%) 0 (0.0%)
Education (n, %)
 5th grade 16 (8.0%)
 2nd grade 11 (5.5%)
 4th grade 11 (5.5%)
 3rd grade 6 (3.0%)
 Preschool 4 (2.0%)
 1st grade 3 (1.5%)
 7th grade 16 (8.0%)
 8th grade 15 (7.5%)
 6th grade 12 (6.0%)
 9th grade 12 (6.0%)
 10th grade 7 (3.5%)
 11th grade 3 (1.5%)
 12th grade 1 (0.5%)
 Other 6 (3.0%) 6 (3.0%)
 College or university degree (2- or 4-year) 32 (16.0%)
 Graduate degree 17 (8.5%)
 High school diploma (or GED) or less 16 (8.0%)
 Some college or certificate program 7 (3.5%)
Overall health (n, %)
 Excellent 28 (40.0%) 40 (50.6%) 6 (8.0%)
 Very good 31 (44.3%) 28 (35.4%) 17 (22.7%)
 Good 10 (14.3%) 10 (12.7%) 38 (50.7%)
 Fair 1 (1.4%) 1 (1.3%) 8 (10.7%)
 Poor 0 (0.0%) 0 (0.0%) 6 (8.0%)
Participant impression of overall GHD severity (n, %)
 Very mild 0 (0.0%) 0 (0.0%) 0 (0.0%)
 Mild 2 (2.9%) 7 (8.9%) 6 (8.0%)
 Moderate 33 (47.1%) 40 (50.6%) 29 (38.7%)
 Severe 28 (40.0%) 27 (34.2%) 27 (36.0%)
 Very severe 7 (10.0%) 5 (6.3%) 13 (17.3%)

Notes: *A total of 302 patients were screened, and of these 224 patients were eligible to participate and completed the study.